SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-018641
Filing Date
2022-09-19
Accepted
2022-09-19 16:08:21
Documents
12
Period of Report
2022-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lbph-20220913.htm   iXBRL 8-K 66012
  Complete submission text file 0000950170-22-018641.txt   197108

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20220913.xsd EX-101.SCH 2495
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20220913_pre.xml EX-101.PRE 11993
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20220913_lab.xml EX-101.LAB 18448
6 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20220913_htm.xml XML 5112
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 221250700
SIC: 2834 Pharmaceutical Preparations